These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8722081)

  • 1. The possible role of insulin release in cardiovascular morbidity and mortality in NIDDM patients.
    Pontiroli AE; Pacchioni M; Camisasca R; Pozza G
    Diabetes Care; 1995 Nov; 18(11):1506. PubMed ID: 8722081
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients.
    Jermendy G
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S370-4. PubMed ID: 14704871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes.
    Chaturvedi N; Fuller JH
    Diabetes Care; 1995 Jun; 18(6):766-74. PubMed ID: 7555501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
    Palumbo PJ
    J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia and cardiovascular risk in NIDDM.
    Uusitupa MI; Niskanen LK
    Diabetes Care; 1995 Jun; 18(6):884-5. PubMed ID: 7555522
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study.
    Perotto M; Panero F; Gruden G; Fornengo P; Lorenzati B; Barutta F; Ghezzo G; Amione C; Cavallo-Perin P; Bruno G
    Acta Diabetol; 2013 Aug; 50(4):563-8. PubMed ID: 22068621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives.
    Beck-Nielsen H; Henriksen JE; Alford F; Hother-Nielson O
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S78-84. PubMed ID: 8894487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular morbidity and mortality in type 2 diabetic patients: a 22-year historical cohort study in Dutch general practice.
    de Grauw WJ; van de Lisdonk EH; van den Hoogen HJ; van Weel C
    Diabet Med; 1995 Feb; 12(2):117-22. PubMed ID: 7743757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk in diabetes: a brief review.
    Marks JB; Raskin P
    J Diabetes Complications; 2000; 14(2):108-15. PubMed ID: 10959073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is type 2 diabetes a different disease in obese and nonobese patients?
    Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P
    Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM).
    Beck-Nielsen H; Henriksen JE; Vaag A; Hother-Nielsen O
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S13-25. PubMed ID: 8529505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topics in cardiovascular disease and diabetes.
    Bloomgarden ZT
    Diabetes Care; 1997 Oct; 20(10):1624-7. PubMed ID: 9314647
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of obesity on development of microangiopathy in the patients with non-insulin dependent diabetes mellitus (NIDDM).
    Kitamura S
    Diabetes Res Clin Pract; 1990; 10 Suppl 1():S221-3. PubMed ID: 2286135
    [No Abstract]   [Full Text] [Related]  

  • 19. Serving diabetes and cardiology: round three of the South African diabetologist/cardiologist debate.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(3):161-3. PubMed ID: 21713308
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiorespiratory fitness and mortality in diabetic men with and without cardiovascular disease.
    McAuley P; Myers J; Emerson B; Oliveira RB; Blue CL; Pittsley J; Froelicher VF
    Diabetes Res Clin Pract; 2009 Sep; 85(3):e30-3. PubMed ID: 19524317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.